MELISSA BOTERO: Open Payments
NPI 1982246864 · PLANTATION, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$414 in 18 payments from 11 companies in 2025. Trend: 2023 $204 · 2024 $321 · 2025 $414
Food & beverage: $414
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $82 |
| TerSera Therapeutics LLC | 2 | $69 |
| Daiichi Sankyo Inc. | 2 | $59 |
| Lilly USA, LLC | 3 | $55 |
| Genentech USA, Inc. | 1 | $31 |
| Myriad Genetic Laboratories, Inc. | 1 | $27 |
| Stemline Therapeutics Inc. | 1 | $23 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $20 |
| PFIZER INC. | 1 | $18 |
| Agios Pharmaceuticals, Inc. | 1 | $15 |
Products named: KEYTRUDA, Zoladex, Enhertu, VERZENIO, Itovebi, MYRISK, Orserdu, NERLYNX.
Industry payments across FL — which companies pay providers there.
